(Q43918962)

28 November 2017

title

Intra-arterial delivery of p53-containing adenoviral vector into experimental brain tumors (English)

1 reference

28 November 2017

1 reference

Tatsuya Abe

1

1 reference

28 November 2017

Hiroaki Wakimoto

2

1 reference

28 November 2017

Robert Bookstein

3

1 reference

28 November 2017

Daniel C Maneval

4

1 reference

28 November 2017

E Antonio Chiocca

5

1 reference

28 November 2017

James P Basilion

6

1 reference

28 November 2017

publication date

1 March 2002

1 reference

28 November 2017

1 reference

28 November 2017

volume

9

1 reference

28 November 2017

issue

3

1 reference

28 November 2017

page(s)

228-235

1 reference

Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700437

Thymidine kinase gene therapy for human malignant glioma, using replication-deficient retroviruses or adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700437

Thymidine kinase activation of ganciclovir in recurrent malignant gliomas: a gene-marking and neuropathological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700437

Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700437

Efficient gene transfer to human squamous cell carcinomas by the herpes simplex virus type 1 amplicon vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700437

Oncolytic virus therapy of multiple tumors in the brain requires suppression of innate and elicited antiviral responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700437

Complement depletion facilitates the infection of multiple brain tumors by an intravascular, replication-conditional herpes simplex virus mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700437

A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700437

Development and characterization of recombinant adenoviruses encoding human p53 for gene therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700437

Purification of a type 5 recombinant adenovirus encoding human p53 by column chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700437

Analytical anion-exchange HPLC of recombinant type-5 adenoviral particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700437

Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700437

Characterization of angiogenesis and microcirculation of high-grade glioma: an intravital multifluorescence microscopic approach in the athymic nude mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700437

Histochemical staining following LacZ gene transfer underestimates transfection efficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700437

Efficacy of multiple administrations of a recombinant adenovirus expressing wild-type p53 in an immune-competent mouse tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700437

Prolonged transgene expression in glomeruli using an EBV replicon vector system combined with HVJ liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700437

Adenovirus-mediated p53 gene delivery potentiates the radiation-induced growth inhibition of experimental brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700437

Sensitization of tumors to chemotherapy through gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700437

Adenovirus-mediated p53 gene therapy for human gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700437

Chemosensitivity of human malignant glioma: modulation by p53 gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700437

Sensitization of rat glioblastoma multiforme to cisplatin in vivo following restoration of wild-type p53 function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700437

The INK4a/ARF tumor suppressor: one gene--two products--two pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700437

7 January 2021

p16INK4A and p19ARF act in overlapping pathways in cellular immortalization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700437

7 January 2021

Adenovirus-mediated p53 gene delivery inhibits 9L glioma growth in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700437

7 January 2021

Mapping the in vivo distribution of herpes simplex virions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700437

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7700437

1 reference

Dimensions Publication ID

28 November 2017

1034974302

0 references

1 reference